DURECT Manufacture and Supply During Clinical Phase. (a) Subject to the terms and conditions set forth herein, DURECT shall manufacture and supply to PTI, and PTI shall purchase from DURECT: (i) [* * *] described in the written specifications designated by the JDT therefor in accordance with Section 5.1(b) (collectively, the “SABER™ Ingredients”) for manufacture of Licensed Products used in the conduct of the Clinical Program and (ii) [* * *] as designated by the JDT ([* * *], the “Bulk Dosage Form”).
Appears in 3 contracts
Samples: Development and License Agreement (Durect Corp), Development and License Agreement (Durect Corp), Development and License Agreement (Durect Corp)
DURECT Manufacture and Supply During Clinical Phase. (a) Subject to the terms and conditions set forth herein, DURECT shall manufacture and supply to PTI, and PTI shall purchase from DURECT: (i) [* * *] described in the written specifications designated by the JDT therefor in accordance with Section 5.1(b) (collectively, *** Material has been omitted pursuant to a request for confidential treatment and such material has been filed separately with the SEC. the “SABER™ Ingredients”) for manufacture of Licensed Products used in the conduct of the Clinical Program and (ii) [* * *] as designated by the JDT ([* * *], the “Bulk Dosage Form”).
Appears in 1 contract
Samples: Development and License Agreement (Pain Therapeutics Inc)